Dr. Sam Asgarian Vice President, Clinical Development for Screening, Guardant Health speaks with Matt Gagnon. March is National Colon Cancer Awareness Month
He talks about Colan Cancer screening, and the Shield blood test, the first and only blood test approved by the FDA as a primary screening option for CRC for average-risk individuals ages 45 and older.